Maria V. Sinegubova
Federal State Institution, , 60 Let Oktjabrja Pr T 7, Bld. 1
Moscow, MOW 117312, Russian Federation
Moscow, MOW 117312, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Production of a Dulaglutide Analogue by Apoptosis-Resistant Chinese Hamster Ovary Cells in a 3-Week Fed-Batch Process.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 18, 2025
A highly specific aptamer for the SARS-CoV-2 spike protein from the authentic strain.
Journal: Organic & biomolecular chemistry
Published: July 08, 2024
Enhancing Human Glycoprotein Hormones Production in CHO Cells Using Heterologous Beta-Chain Signal Peptides.
Journal: Doklady. Biochemistry and biophysics
Published: October 09, 2023
Fast and Accurate Surrogate Virus Neutralization Test Based on Antibody-Mediated Blocking of the Interaction of ACE2 and SARS-CoV-2 Spike Protein RBD.
Journal: Diagnostics (Basel, Switzerland)
Published: December 16, 2021
Purification Process of a Recombinant Human Follicle Stimulating Hormone Biosimilar (Primapur®) to Yield a Pharmaceutical Product with High Batch-to-Batch Consistency.
Journal: Pharmaceutics
Published: November 29, 2021
Targeted Knockout of the dhfr, glul, bak1, and bax Genes by the Multiplex Genome Editing in CHO Cells.
Journal: Doklady. Biochemistry and biophysics
Published: November 01, 2021
Antigenic properties of the SARS-CoV-2 nucleoprotein are altered by the RNA admixture.
Journal: PeerJ
Published: August 11, 2021
High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector.
Journal: PloS one
Published: November 19, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026